CRA named to 2020 Global Arbitration Review’s Expert Witness Firms’ Power Index
Charles River Associates has been recognized in the 2020 Global Arbitration Review’s Expert Witness Firms’ Power Index. CRA was ranked as a top-two firm in...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Andrew Tepperman is a vice president in CRA’s Life Sciences Practice. Dr. Tepperman has deep experience conducting economic analyses in legal matters involving intellectual property, antitrust, and other commercial disputes, including international arbitrations.
Within the life sciences sector, he has had many engagements involving damages assessment for patent and trade secret infringement, ANDA litigation, patent settlement agreements, monopolization, and breach of contract claims. He has provided expert testimony in Canadian and U.S. court proceedings.
Before joining CRA in 2001, Dr. Tepperman lectured at the University of Toronto and conducted research funded by Industry Canada on the international determinants of patenting. His doctoral dissertation, entitled “The Implications of Intellectual Property Rights for Firm Strategy and Organizational Choice,” was completed in 2001.